Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
about
Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activityReduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression.Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancerEGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanismTranscriptional cross talk between orphan nuclear receptor ERRγ and transmembrane transcription factor ATF6α coordinates endoplasmic reticulum stress response.Receptor-based targeting of therapeutics.The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer.Role of steroid receptor and coregulator mutations in hormone-dependent cancers.Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.Investigation the mechanism of the apoptosis induced by lactacystin in gastric cancer cells.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.Age-related cataracts: Role of unfolded protein response, Ca2+ mobilization, epigenetic DNA modifications, and loss of Nrf2/Keap1 dependent cytoprotection.Maternal Obesity, Cage Density, and Age Contribute to Prostate Hyperplasia in Mice.Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.Emerging mechanisms of enzalutamide resistance in prostate cancer.Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
P2860
Q26782111-F72BC22C-FFC4-4071-9B6F-020A6B06AA74Q35111955-01853B46-F957-4201-B73E-91D254EE6B45Q35631971-BF4B1912-FD7C-4BDF-A763-1C4F6037FFD5Q36168253-155031C2-8097-4920-AC41-37DE582952F7Q37080357-2C4F8F84-4D2D-46BB-A9ED-6F7B3DB048ADQ38084739-873AA384-48CB-44F9-B207-E5B1C20D562EQ38342823-F0BF4CAE-094F-42E8-8FA7-D2B50922A8C3Q38736287-F5773EB6-C33B-42FB-B3F8-40E24B6FD44AQ38827723-F4138094-43EF-436A-A0D5-054A1A460279Q38925409-1B2DDC44-73A8-4CD6-8160-1103146CFF9BQ39016544-37AABE78-6B64-4ED4-B1E6-A88E9709717AQ39223255-7AAF7016-D2F8-4A0E-B600-B4975D45C8D2Q41282756-CED22C50-BAEB-4E8E-A7CB-C96DB6E52DD6Q41824705-FBB2E982-F01B-4347-9245-C3A69BBC20F9Q46313125-E71C9E4C-735C-4B98-A93A-85FE35E2D07BQ50573927-D2E6BA5C-7CDA-43E3-A549-EAB228523E4BQ52730051-C4BC9D21-760B-4510-8EDC-01D69095AB1AQ55058538-59220679-6ECB-48C3-ACA6-640FDB457F16Q55281041-1B412FB7-D57D-4618-8AC9-04109457E7BF
P2860
Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Differential targeting of andr ...... a novel therapeutic modality.
@ast
Differential targeting of andr ...... a novel therapeutic modality.
@en
type
label
Differential targeting of andr ...... a novel therapeutic modality.
@ast
Differential targeting of andr ...... a novel therapeutic modality.
@en
prefLabel
Differential targeting of andr ...... a novel therapeutic modality.
@ast
Differential targeting of andr ...... a novel therapeutic modality.
@en
P2093
P2860
P356
P1433
P1476
Differential targeting of andr ...... a novel therapeutic modality.
@en
P2093
Alexander Yemelyanov
Andrey Ugolkov
Apollon Karseladze
Irina Budunova
Kenichi Iwadate
Pankaj Bhalla
Ximing Yang
P2860
P304
P356
10.4161/CC.11.2.18945
P577
2012-01-15T00:00:00Z